Prostate Cancer - Results from #18260

Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health-related quality-of-life outcomes - Abstract June 16, 2015

Targeting the bone microenvironment in metastatic castration-resistant prostate cancer - Abstract June 16, 2015

Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer - Abstract June 16, 2015

Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis - Abstract June 15, 2015

Declining use of radiotherapy for adverse features after radical prostatectomy: Results from the National Cancer Data Base - Abstract June 15, 2015

Twelve core template prostate biopsy is an unreliable tool to select patients eligible for focal therapy - Abstract June 15, 2015

Factors associated with men's assessment of prostate cancer treatment choice - Abstract June 12, 2015

Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial - Abstract June 12, 2015

Large cell differentiation of metastatic prostate cancer after androgen deprivation therapy - Abstract June 12, 2015

Assessing the optimum use of androgen-deprivation therapy in high-risk prostate cancer patients undergoing external beam radiation therapy - Abstract June 12, 2015

Impact of obesity on pathologic outcomes and biochemical recurrence after radical prostatectomy - Abstract June 12, 2015

Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study - Abstract June 12, 2015

A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? - Abstract June 12, 2015

Comparison of pathological data between prostate biopsy and radical prostatectomy specimen in patients with low to very low risk prostate cance - Abstract June 12, 2015

Comparative effectiveness of mitoxantrone plus prednisone versus prednisone alone in metastatic castrate-resistant prostate cancer after docetaxel failure - Abstract June 12, 2015

Immunotherapy in prostate cancer - Abstract June 12, 2015

Integrated Medical Professionals’ director of pathology to serve on national board June 12, 2015

Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): - Abstract June 12, 2015

Weighted Gleason scores do not outperform standard clinical Gleason scores - Abstract June 12, 2015

Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: The Prostate Cancer Treatment, your experience (PiCTure) study - Abstract June 11, 2015

Page 914 of 1457